Kapusta Matthew C
CIK 0001536290
CEO, Managing DirectorDirector
Filings
19
Latest Mar 6, 2026
Issuers covered
2
Showing
19 of 19
Page 1
Track record
20 of 20 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 20 | 50% | -16.1% | -1.1% | +40.6% | -118.2% |
| 90 days | 20 | 65% | -7.6% | +8.4% | +49.1% | -196.0% |
| 180 days | 17 | 59% | +15.0% | +57.7% | +66.5% | -131.7% |
| 365 days | 12 | 42% | -15.9% | -23.1% | +75.7% | -184.9% |
Issuers
Companies where Kapusta Matthew C has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| QURE | Uniqure N.V. | 17 | Mar 6, 2026 |
| DBTX | Decibel Therapeutics, Inc. | 2 | Sep 25, 2023 |
All filings
19 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|